-
Jan 27 2014
Indian pharma firms can’t be judged by US standards: G.N. Singh The drug controller general of India says many multinational pharma firms stand to gain if India loses its image as a supplier of quality drugs
Singh says the process of streamlining the drug regulation in…
Read more -
Jan 27 2014
Ranbaxy Faces FDA Wrath, Doctors Seek Regulator’s remarks. Investors Panic. What Next?
US health regulator Food and Drug Administration has found as…
Read more -
Jan 22 2014
Drug regulator lets pharma firms fix own penalty Resource crunch is coming in the way of the drug regulator’s attempt to prevent over-pricing of medicines
Pharmaceutical companies could enjoy a leeway while pricing their products,…
Read more -
Jan 22 2014
Bill Gates: poverty eradicated by 2035 and innovative pharma growth in India, China and Brazil
Bill Gates: poverty eradicated by 2035 and innovative pharma growth…
Read more -
Jan 22 2014
Indian pharma companies secure 154 ANDAs approval from US FDA during 2013
Indian pharma companies secure 154 ANDAs approval from US FDA…
Read more -
Jan 19 2014
Aurobindo to buy Actavis’ operations in 7 EU nations
Aurobindo Pharma Ltd will acquire the commercial operations of Actavis…
Read more -
Jan 19 2014
Biotech major Biocon has launched CANMab (biosimilar Trastuzumab) for treating breast cancer in the Indian market from next month.
Kiran Mazumdar-Shaw Net Worth $655 M As of October 2013…
Read more -
Jan 15 2014
U.S. health care: A Model T in a Tesla world?
This is not sustainable. It doesn’t work for the people…
Read more -
Jan 15 2014
visitation policy of UK goes for a Change!
LEXINGTON, KY. — UK HealthCare says it has amended its…
Read more -
Jan 15 2014
Breaking News
- ticket title
- Top 50 Entrepreneurs in Pharmaceutical Industry Powering the Global Medicine Chest
- Dr. Koushik Lahiri Issues Urgent Global Clarion Call Against Steroid Dependence Crisis at 17th Pharma Leaders Summit
- Dr. Sudhakar Shinde, IRS, Delivers an Uncompromising Clarion Call for Ethical Governance at the Pharma Leaders 2026 Summit
- Beyond Generics: Venkat Nelabhotla Unveils the ‘Develop, Own, Make’ Blueprint for India’s Global Biotech Ascension
- The Rural Health Crisis: Why Free Policies Aren’t Saving Lives in Deep India
- Vyome CEO Venkat Nelabhotla Unveils the ‘Develop, Own, Make, Commercialize’ Roadmap for Global Life Sciences Leadership in Mumbai
- Pharma Titans & Healthcare Visionaries Honoured — Healthcare Super Brand Awards 2026 Redefine Global Standards at Pharma Leaders Annual Awards
- MGM Institute of Health Sciences Honored as Asia’s Most Prestigious Health Sciences & Patient Centric Institution 2026
- The $1.1 Billion Paradox: Inside Emcure’s High-Stakes Legal Warfare, US FDA Scrutiny, and Leadership Exodus
- Why Healthcare in India Needs Urgent Attention?
